MDI Therapeutics, Inc. — Form D
MDI Therapeutics, Inc. of NOVI, MI, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-08. The offering totals $9.7M, of which $1.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-03-08
- Form: D
- Accession: 0000905729-22-000083
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.7M
- Amount sold: $1.7M
- Remaining: $8.0M
- Investors: 3
- Date of first sale: 2022-02-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-436269
Issuer
- Name: MDI Therapeutics, Inc.
- CIK: 0001732863
- Entity type: Corporation
- Jurisdiction: MICHIGAN
- Incorporated: 2022
- Address: 46430 PEARY COURT, NOVI, MI, 48377
- Phone: 269-370-0775
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Stephen C Benoit | Director | Novi, MI |
| David C Ginsburg | Director | Novi, MI |
| Grazia C Piizzi | Director | Novi, MI |
| Stephen C Benoit | Executive Officer | Novi, MI |
| Duane E Day | Executive Officer | Novi, MI |
| Daniel A Lawrence | Executive Officer | Novi, MI |
| Stephen Benoit | Director | Kalamazoo, MI |
| Stephen Benoit | Executive Officer | Kalamazoo, MI |
| Duane Day | Director | Novi, MI |
| Duane Day | Executive Officer | Novi, MI |
| Daniel Lawrence, Ph.D. | Director | Novi, MI |
| Daniel Lawrence, Ph.D. | Executive Officer | Novi, MI |
Other filings by this issuer (1)
More